Ibrahim Aldoss, MD, discusses the potential of AZD0486 for treating relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and outlines the SYRUS study objectives. AZD0486 is a novel IgG ...
Eli Lilly & Co. on Thursday said its psoriasis treatment ixekizumab showed positive results in phase 3 studies, preparing the way for its submission to regulatory authorities. The treatment met all ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results